V5med
About V5med
V5med Inc. is a pioneering healthcare AI company specializing in advanced diagnostic imaging solutions, particularly for lung and heart conditions. Leveraging over a decade of expertise in high-speed imaging, deep learning, and computer vision from its parent company, V5 Technologies (a leader in semiconductor inspection systems), V5med has developed clinically validated AI algorithms to enhance diagnostic accuracy and efficiency. Their flagship platform utilizes low-dose CT (LDCT) imaging to support the early detection and quantification of lung nodules, emphysema, pulmonary fibrosis, and coronary artery calcification—often in a single scan.
For physicians, V5med’s solutions are designed to be PACS-integrated, vendor-neutral, and scalable across various radiology networks and screening centers. The company’s AI-powered software, such as V5 Lung AI, has received U.S. FDA 510(k) clearance, making it the first AI-based lung diagnostic software company in Taiwan to achieve this milestone. Clinical validation data indicates that their system can increase nodule detection sensitivity by over 95% and improve radiologist accuracy by up to 20%, while also being Lung-RADS® compatible and optimized for detecting ground-glass nodules (GGNs). Beyond lung cancer screening, V5med is expanding its AI portfolio to include tools like AccuCardio for coronary artery calcification analysis and AccuPulmo for pulmonary fibrosis and emphysema detection, aiming to provide comprehensive diagnostic support and improve patient outcomes globally.
Focus Areas
Business Intelligence
| Key Investors | V5 Technologies |
| Partnerships | Clairvo Technologies (Japan), Taipei Veterans General Hospital, National Taiwan University Hospital, Taiwan Lung Cancer Society, St. Med Public Company Limited (SMD) (Thailand), Bangkok Dusit Medical Services (Thailand) |
| Technology | Cloud-native, Deep Convolutional Neural Network (CNN)-based algorithms, PACS-integrated, vendor-neutral, DICOM 3.0 standard compatible |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
V5med's solutions, particularly V5 Lung AI, are designed to significantly enhance diagnostic accuracy and efficiency. Clinical studies have shown a 10% reduction in missed cancers and a 13% decrease in radiologist interpretation time when using V5med Lung AI. The system's ability to provide detailed nodule characteristics, Lung-RADS scoring, and volume doubling time (VDT) analysis offers critical information for clinical decision-making and patient management. Its vendor-neutral and PACS-integrated design ensures seamless integration into existing workflows, minimizing disruption. The U.S. FDA clearance for V5 Lung AI provides a strong assurance of its reliability and performance. Furthermore, the expansion into other thoracic and cardiovascular diagnostics from a single CT scan offers a comprehensive approach to patient care, potentially streamlining multiple diagnostic processes.
V5med's AI solutions are designed for broad compatibility and seamless integration into existing clinical environments. The V5med Lung AI system accepts chest CT images from PACS (Picture Archiving and Communication System), RIS (Radiological Information System), or directly from a CT scanner. It adheres to the DICOM 3.0 standard, ensuring compatibility with various imaging equipment regardless of brand or model, including major manufacturers like Siemens, GE, Philips, and Toshiba. The output annotations regarding lung nodules are provided in DICOM GSPS (Grayscale Softcopy Presentation State) format, requiring a DICOM Viewer that supports this standard for optimal display of marking results. The system can operate offline and is installed on-site by certified engineers, integrating algorithm logic and a database on the same server for ease of maintenance.
What the Web Says
V5med appears to be a company focused on AI-powered medical imaging solutions, specifically V5med Lung AI for detecting pulmonary nodules. Reviews for V5med as an employer are limited and seem to be conflated with other companies named 'V5' or 'Vmed'. Product reviews for V5med Lung AI highlight its effectiveness in improving diagnostic accuracy and reducing reading times for radiologists.
Overall: PositiveStrengths
- Significant increase in AUC for nodule detection (0.0959, 95%CI: (0.0586, 0.1332))
- Significant decrease in reading time (133.0 seconds unaided to 115.9 seconds with AI, a 13% improvement)
- Superior radiologist performance for detecting nodules compared to unaided reads
- Reduces missed cancers by 10% with near the same specificity
- Improves inter-reader agreement in Lung-RADS scores
- Easy to use and maintain due to integrated algorithm logic and database on the same server
Limitations
- No specific cons for V5med Lung AI were found in the provided search results.
- Employer reviews are scarce and often mixed with other similarly named companies, making it difficult to assess V5med specifically.
- Some review platforms like G2 and Capterra have general concerns about review authenticity.
Based on reviews from: Indeed.com, accessdata.fda.gov, V5med Lung AI (product page), G2, Capterra
Last updated: 2026-07-20
Videos
News, demos, and interviews about V5med.
Videos load interactively. If none appear, search YouTube for V5med →
Press & Coverage
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]